文献速递免疫规划传染病防控与疫情报告

铜绿假单胞菌XcpQ蛋白:斑马鱼中具有免疫原性的候选疫苗

XcpQ from Pseudomonas aeruginosa: A potential vaccine candidate with immunogenic properties in zebrafish.
PubMed 文献 · Vaccine · 2026-06-01

本研究评估铜绿假单胞菌II型分泌系统外膜组分XcpQ作为疫苗抗原的潜力。生物信息学预测其抗原性,克隆表达纯化Xcp-AN蛋白,体外检测生物膜形成、A549细胞黏附与毒性,并以斑马鱼为感染模型免疫评价。结果显示Xcp-AN可增加生物膜生物量,不显著介导上皮黏附且细胞毒性低,免疫后斑马鱼鳃部细菌载量较对照组减少63%,提示Xcp-AN是有前景的候选疫苗,但需进一步验证。

要点

  • XcpQ经生物信息学预测为有前景的疫苗候选抗原。
  • Xcp-AN免疫使斑马鱼鳃部细菌载量较对照组减少63%。
  • Xcp-AN在体外对A549细胞黏附无显著介导且细胞毒性低。

核心结论

  • Xcp-AN结构域是抗铜绿假单胞菌疫苗开发的有前景候选,但需更多研究验证其疫苗效力。

研究设计与样本

  • 研究将XcpQ基因克隆至pET28a+载体(BamHI和SacI位点),在大肠杆菌BL21(DE3)中以1 mM IPTG诱导表达,经Ni-NTA柱纯化Xcp-AN异源蛋白。
  • 体外评估Xcp-AN对生物膜形成、对A549人肺泡上皮细胞系黏附及MTT法细胞毒性的影响。
  • 以斑马鱼(Danio rerio)作为体内感染模型评价Xcp-AN免疫效果。

主要发现

  • 铜绿假单胞菌暴露于6.5 μg/ml Xcp-AN后生物膜生物量增加46.41%。
  • 在感染复数100:1(细菌比A549细胞)下未观察到可检测的细菌黏附,提示Xcp-AN不显著介导上皮细胞附着。
  • MTT试验中不同浓度Xcp-AN处理后超过99%的A549细胞保持存活。
  • Xcp-AN免疫使斑马鱼鳃部细菌较对照组减少63%。

临床怎么用

  • Xcp-AN的低细胞毒性和免疫后减少鳃部细菌载量支持其作为抗铜绿假单胞菌疫苗候选进一步开发。

局限性

  • 原文指出需额外研究验证Xcp-AN作为疫苗候选的效力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

XCP is one of two major subtypes of the type II secretion system in Pseudomonas aeruginosa strains. XcpQ, the outer-membrane component of Xcp, facilitates protein secretion. This study aimed to evaluate the potential of XcpQ as a vaccine antigen against P. aeruginosa. Bioinformatics and immunoinformatics analyses identified XcpQ as a promising vaccine candidate based on antigenicity and epitope prediction. The XcpQ gene was cloned into the pET28a+ vector using BamHI and SacI, and the construct was induced in E. coli BL21(DE3) with IPTG to a final concentration of 1 mM. The Xcp-AN (heterologous protein) was purified using a Ni-NTA column. The function of the Xcp-AN was investigated with respect to biofilm formation, adherence to the A549 human alveolar epithelial cell line (A549), and cytotoxicity was assessed via the MTT assay. Zebrafish (Danio rerio) served as the in vivo infection model. Exposure of P. aeruginosa to 6.5 μg/ml of Xcp-AN led to a 46.41% increase in biofilm biomass. At a multiplicity of infection (MOI) of 100:1 (bacteria to A549 cells), no detectable bacterial adherence was observed, suggesting that Xcp-AN does not significantly mediate epithelial cell attachment. Over 99% of A549 cells retained viability following treatment with varying concentrations of Xcp-AN in the MTT assay. Immunization with Xcp-AN resulted in a 63% reduction in gill bacteria in zebrafish compared to the control group. Overall, these results suggest that the Xcp-AN domain is a promising candidate for vaccine development against P. aeruginosa. However, additional research is necessary to verify its efficacy as a vaccine candidate.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nouhi A, Abolmaali S, Darvish Alipour Astaneh S, et al. XcpQ from Pseudomonas aeruginosa: A potential vaccine candidate with immunogenic properties in zebrafish. Vaccine. 2026. PMID: 42224772. doi:10.1016/j.vaccine.2026.128768

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。